Exane Asset Management Abb Vie Inc. Transaction History

Exane Asset Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 05, 2019	SELL	$77.85 - $96.01 $230,903 - $284,765	-2,966 Closed	0 $0
Q3 2018 Nov 16, 2018	BUY	$88.91 - $98.84 $213,117 - $236,919	2,397 Added 421.27%	2,966 $0
Q2 2018 Sep 06, 2018	SELL	$89.78 - $106.23 $469,639 - $555,689	-5,231 Reduced 90.19%	569 $0
Q1 2018 Apr 30, 2018	BUY	$92.01 - $123.21 $533,658 - $714,618	5,800 New	5,800 $0
Q4 2017 Feb 08, 2018	SELL	$89.56 - $98.21 $250,768 - $274,988	-2,800 Closed	0 $0
Q3 2017 Oct 13, 2017	BUY	$69.85 - $89.22 $195,579 - $249,816	2,800	2,800 $249 Million

3,848

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Exane Asset Management, based on Form 13F filings with the SEC.

Stay updated on Exane Asset Management with notifications on news.